<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PARP1-targeted contrast agent &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/parp1-targeted-contrast-agent/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:50:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>PARP1-targeted contrast agent &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>New Fluorescent Imaging Method Enables Rapid and Safe Detection of Basal Cell Carcinoma</title>
		<link>https://bioengineer.org/new-fluorescent-imaging-method-enables-rapid-and-safe-detection-of-basal-cell-carcinoma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 21 Aug 2025 20:30:35 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Dermatological molecular imaging]]></category>
		<category><![CDATA[Fluorescent imaging diagnostics]]></category>
		<category><![CDATA[Noninvasive BCC detection]]></category>
		<category><![CDATA[PARP1-targeted contrast agent]]></category>
		<category><![CDATA[Skin cancer innovation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-fluorescent-imaging-method-enables-rapid-and-safe-detection-of-basal-cell-carcinoma/</guid>

					<description><![CDATA[A groundbreaking advancement in dermatological diagnostics has emerged with the development of a novel fluorescent molecular contrast agent known as PARPi-FL. This innovative compound enables the rapid and noninvasive detection of basal cell carcinoma (BCC), the most prevalent form of skin cancer, directly through intact human skin. According to preclinical investigations published in the August [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">256831</post-id>	</item>
	</channel>
</rss>
